ENTITY
Bristol Myers Squibb Co

Bristol Myers Squibb Co (BMY US)

237
Analysis
Health Care • United States
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
more
•12 Sep 2016 22:34

US Stock Market Seasonality:  Shemitah Redux, The Afterparty

Almost exactly a year ago I wrote a piece on stock market seasonality titled Stock Market Seasonality - Januaries, SuperBowls, Third Years,...

Logo
426 Views
Share
•05 Sep 2016 08:03

ANIMAL SPIRITS REPORT 2: APAC Valuation and Earnings Snapshot

Asia Pacific Investment Strategy  In this series of introductory notes, Animal Spirits outlines the investment process and analytical framework we...

Share
•16 Aug 2016 08:36

Our Ultimate Stock-Pickers Top 10 New-Money Purchases

Our early read on the buying and selling activity of our top managers during the second quarter uncovered a few nuggets. New-money purchases were...

Share
•09 Aug 2016 18:52

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Logo
350 Views
Share
•07 Jul 2016 10:21

No Pain, Potential for Lots of Gain for Pfizer, Lilly, and Regeneron

The history of pain drugs that target nerve growth factor has been a roller-coaster ride for drug developers and investors. In 2010, expectations...

Share
x